IGF2R antibody [MEM-238] (APC)
GTX79972
Overview
- SupplierGeneTex
- Product NameIGF2R antibody [MEM-238] (APC)
- Delivery Days Customer9
- Antibody SpecificityThis antibody recognizes an epitope between amino acids 192-697 of CD222 (IGF2 receptor).
- Application Supplier NoteFACS: 10 microl reagent / 100 microl of whole blood or 106 cells in a suspension. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- Clone IDMEM-238
- FormulationLiquid
- Gene ID3482
- Target nameIGF2R
- Target descriptioninsulin like growth factor 2 receptor
- Target synonyms300 kDa mannose 6-phosphate receptor; cation-independent mannose-6-phosphate receptor; CD222; CI Man-6-P receptor; CI-M6PR; CIMPR; IGF-II receptor; insulin-like growth factor II receptor; M6P/IGF2 receptor; M6P/IGF2R; M6P-R; MPR 300; MPR1; MPR300; MPRI
- Protein IDP11717
- Protein NameCation-independent mannose-6-phosphate receptor
- Scientific DescriptionThis gene encodes a receptor for both insulin-like growth factor 2 and mannose 6-phosphate. The binding sites for each ligand are located on different segments of the protein. This receptor has various functions, including in the intracellular trafficking of lysosomal enzymes, the activation of transforming growth factor beta, and the degradation of insulin-like growth factor 2. Mutation or loss of heterozygosity of this gene has been association with risk of hepatocellular carcinoma. The orthologous mouse gene is imprinted and shows exclusive expression from the maternal allele; however, imprinting of the human gene may be polymorphic, as only a minority of individuals showed biased expression from the maternal allele (PMID:8267611). [provided by RefSeq, Nov 2015]
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- The role of insulin-like growth factor in Acrochordon Etiopathology. Koeseoglu HG et al., 2020 Nov 3, BMC DermatolRead more
- Adjunctive albuterol enhances the response to enzyme replacement therapy in late-onset Pompe disease. Koeberl DD et al., 2014 May, FASEB JRead more
- Adjunctive beta2-agonists reverse neuromuscular involvement in murine Pompe disease. Li S et al., 2013 Jan, FASEB JRead more
- Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle. Koeberl DD et al., 2011 Jun, Mol Genet MetabRead more